None listed
Conditions
Interventions
Control Group ( Group A):Normal saline
Shugeng Glucose Sodium 3mg/kg Group (Group B):3mg/kg Shugeng Glucose Sodium
Shugeng Glucose Sodium 4mg/kg Group (Group C):4mg/kg Shugeng Glucose Sodium
Sponsors
Department of Anesthesiology, the Second Affiliated Hospital of Guangxi Medical University
Eligibility
Sex/Gender
All
Age
60 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. The operation time is expected to be > 60 minutes; 2. Gender is not limited, ASA grade ?~?, aged 60 ~ 85 years; 3. BMI 18 ~ 30 kg/m^2; 4. Non-pulmonary surgery for elderly patients; 5. Able to understand the procedures and methods of this study, willing to sign informed consent and strictly follow the clinical study protocol to complete this study.
Exclusion criteria
Exclusion criteria: 1. The airway classification of Mallampati was higher than grade ?; 2. Abnormal liver and kidney function; 3. Known or suspected neuromuscular disease; 4. Diabetes complicated with peripheral neuropathy; 5. History of allergy to narcotic drugs; 6. History of malignant hyperthermia; 7. Taking phenytoin sodium, carbonic acid and other drugs that can interact with rocuronium; 8. Mental illness; 9. Abnormal coagulation function; 10. Have a history of alcoholism; 11. Intraoperative blood loss exceeding 800ml.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time of onset of muscle relaxation antagonist;Recovery time of postoperative spontaneous breathing;Consciousness recovery time;Tracheal tube removal time; | — |
Countries
China
Contacts
Public ContactMa Xiangfei
The Second Affiliated Hospital of Guangxi Medical University
Outcome results
None listed